Ketki Bhise
- Oncology top 2%
- Immunology top 5%
- Molecular Biology
- Biomedical Engineering top 10%
- Biomaterials top 5%
- Co-authors
- Arun K. IyerSamaresh SauHashem O. AlsaabSushil K. KashawRami M. AlzhraniKatyayani TatipartiRakesh Kumar TekadeMohd Cairul Iqbal Mohd Amin
- Topics
- Nanoplatforms for cancer theranostics (8 papers)Nanoparticle-Based Drug Delivery (6 papers)Cancer Immunotherapy and Biomarkers (5 papers)
- Cited by
- OncologyImmunologyBiomaterials
- Partner nations
- United StatesSaudi ArabiaIndia
In The Last Decade
Ketki Bhise
17 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 996
- Immunology 639
- Molecular Biology 560
- Biomedical Engineering 382
- Biomaterials 269
Countries citing papers authored by Ketki Bhise
This map shows the geographic impact of Ketki Bhise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ketki Bhise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ketki Bhise more than expected).
Fields of papers citing papers by Ketki Bhise
This network shows the impact of papers produced by Ketki Bhise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ketki Bhise. The network helps show where Ketki Bhise may publish in the future.
Co-authorship network of co-authors of Ketki Bhise
This figure shows the co-authorship network connecting the top 25 collaborators of Ketki Bhise. A scholar is included among the top collaborators of Ketki Bhise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ketki Bhise. Ketki Bhise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 13 | |
| 3 | 12 | |
| 4 | 1 | |
| 5 | 44 | |
| 6 | 45 | |
| 7 | 4 | |
| 8 | 46 | |
| 9 | 3 | |
| 10 | 65 | |
| 11 | 125 | |
| 12 | 1 | |
| 13 | 23 | |
| 14 | 87 | |
| 15 | PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcomebreakdown → | 1288 |
| 16 | 48 | |
| 17 | 166 |
About Ketki Bhise
Ketki Bhise is a scholar working on Biomaterials, Molecular Medicine and Microbiology, having authored 17 papers that have together received 2.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (996 citations), Immunology (639 citations) and Biomaterials (269 citations). Ketki Bhise has collaborated with scholars based in United States, Saudi Arabia and India. Frequent co-authors include Arun K. Iyer, Samaresh Sau, Hashem O. Alsaab, Sushil K. Kashaw, Rami M. Alzhrani, Katyayani Tatiparti, Rakesh Kumar Tekade, Mohd Cairul Iqbal Mohd Amin, Umesh Gupta and Prashant Kesharwani. Their work appears in journals such as Cancer Research, The FASEB Journal and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.